Targets Of Senescence In Cardiac Muscle: Insights For Regenerative Treatments In The Aged Heart
As we age, our hearts become more susceptible to disease, and treatments aimed at regenerating heart tissue often fall short in older individuals. A major culprit behind this challenge is the accumulation of “senescent cells” – often referred to as zombie cells – within the heart. These cells stop dividing and, instead of dying off, they release a cocktail of harmful substances called the senescence-associated secretory phenotype (SASP). This creates a toxic environment that fuels inflammation, leads to scarring (fibrosis), and ultimately hinders the heart’s natural ability to repair itself.
However, promising new research suggests a way to combat this. Therapies known as senotherapeutics, particularly senolytic drugs, are designed to selectively eliminate these problematic senescent cells. By clearing out these zombie cells, we can alleviate many of the detrimental features of an aging heart, such as weakened muscle function, abnormal enlargement, and excessive scarring. More importantly, removing these cells can reactivate the heart’s inherent capacity for regeneration.
This approach holds significant promise for rejuvenating the heart’s microenvironment, making it more receptive to other regenerative treatments, whether they involve cells or genes. The future of heart repair in older patients may lie in first clearing out these senescent cells to create a healthier, more regenerative foundation.
Source: link to paper